ProMIS Neurosciences (NASDAQ:PMN) Receives “Buy” Rating from Guggenheim
Guggenheim reiterated their buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report issued on Wednesday,Benzinga reports. ProMIS Neurosciences Stock Down 0.3 % ProMIS Neurosciences stock opened at $0.73 on Wednesday. ProMIS Neurosciences has a 12-month low of $0.65 and a 12-month high of $2.61. The business’s 50-day moving average price […]
Guggenheim reiterated their buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report issued on Wednesday,Benzinga reports. ProMIS Neurosciences Stock Down 0.3 % ProMIS Neurosciences stock opened at $0.73 on Wednesday. ProMIS Neurosciences has a 12-month low of $0.65 and a 12-month high of $2.61. The business’s 50-day moving average price […]
